LSE - Delayed Quote USD

Aflac Incorporated (0H68.L)

83.59 -0.19 (-0.23%)
At close: April 26 at 6:45 PM GMT+1
Key Events
Loading Chart for 0H68.L
DELL
  • Previous Close 83.78
  • Open 80.00
  • Bid --
  • Ask --
  • Day's Range 80.00 - 83.76
  • 52 Week Range 60.54 - 86.30
  • Volume 1,108
  • Avg. Volume 9,591
  • Market Cap (intraday) 615.631M
  • Beta (5Y Monthly) 0.91
  • PE Ratio (TTM) 0.14
  • EPS (TTM) 6.09
  • Earnings Date May 1, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.

www.aflac.com

12,785

Full Time Employees

December 31

Fiscal Year Ends

--

Sector

--

Industry

Recent News: 0H68.L

Performance Overview: 0H68.L

Trailing total returns as of 4/28/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

0H68.L
1.60%
MSCI WORLD
5.23%

1-Year Return

0H68.L
23.64%
MSCI WORLD
18.44%

3-Year Return

0H68.L
60.41%
MSCI WORLD
12.98%

5-Year Return

0H68.L
75.65%
MSCI WORLD
53.42%

Compare To: 0H68.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0H68.L

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    24.91%

  • Return on Assets (ttm)

    2.64%

  • Return on Equity (ttm)

    22.12%

  • Revenue (ttm)

    18.7B

  • Net Income Avi to Common (ttm)

    4.66B

  • Diluted EPS (ttm)

    6.09

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.62B

  • Total Debt/Equity (mrq)

    42.24%

  • Levered Free Cash Flow (ttm)

    4.31B

Company Insights: 0H68.L

People Also Watch